Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,066,000
-22,000 (-2.02%)
At close: Jul 25, 2025, 3:30 PM KST
Samsung Biologics Market Cap
Samsung Biologics has a market cap or net worth of 75.87 trillion as of July 25, 2025. Its market cap has increased by 45.63% in one year.
Market Cap
75.87T
Enterprise Value
76.01T
Revenue
4.90T
Ranking
n/a
PE Ratio
59.30
Stock Price
1,066,000.00
Market Cap Chart
Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 75.87T, an increase of 696.32%. That is a compound annual growth rate of 26.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 75.87T | 12.33% |
| Dec 30, 2024 | 67.54T | 24.87% |
| Dec 28, 2023 | 54.09T | -7.43% |
| Dec 29, 2022 | 58.43T | -2.20% |
| Dec 30, 2021 | 59.75T | 9.32% |
| Dec 30, 2020 | 54.65T | 90.76% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 39.24T |
| ALTEOGEN | 24.69T |
| Yuhan | 9,152.41B |
| SK Biopharmaceuticals | 8,034.94B |
| Peptron | 6,663.04B |
| HLB Co., Ltd. | 6,558.63B |
| PharmaResearch | 5,797.42B |
| Sam Chun Dang Pharm. | 5,349.22B |